Enough Re - ReWith an Exro ( research/tech ) - let's not belabour - hr to hr - let's look back - collaborations in 2020 - top line planning- the share offering price and strategy - less so - However - the future - walking the talk - I'm long in Exro - prototypes , multi.industry - if they do nothing but add regenerative braking to CNR and CPR trains - downhill through the Rockies - saleable, beneficial --- and with greater personnel safety benefits! What's now to like ??